Reneo Pharmaceuticals
Balance Sheet

Last updated:

The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Reneo Pharmaceuticals's balance sheet done over the years? Its assets were worth $107,436,000 last year, which is less than in the previous period. 18% of Reneo Pharmaceuticalsโ€™s total assets is currently financed by debt. Its liabilities reached the amount of $18,826,000, which means an increase by 129% compared compared to last year.

Debt to Assets

Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM): Debt to assets
2019 25505000 48.63M 190.68%
2020 55221000 97.33M 176.27%
2021 154024000 6.81M 4.42%
2022 108182000 8.21M 7.59%
2023 107436000 18.82M 17.52%

RPHM Balance Sheet (2019 โ€“ 2023)

2023 2022 2021 2020 2019
Assets
Current assets:
Cash and cash equivalents
27.63M19.92M124.66M53.61M17.50M
Short term investments
75.33M81.24M23.01M07.38M
Net receivables
00000
Inventory
00000
Other current assets
3.65M5.18M6.06M1.41M519K
Total current assets
106.62M106.35M153.73M55.02M25.40M
Non-current assets:
Property, Plant and Equipment
733K1.74M212K69K79K
Goodwill
00000
Intangible assets
00000
Long term investments
00000
Other non-current assets
81K84K78K127K20K
Total non-current assets
814K1.82M290K196K99K
Total assets
107.43M108.18M154.02M55.22M25.50M
Liabilities
Current liabilities:
Accounts payable
Deferred revenue
00000
Short term debt
662K404K000
Total current liabilities
18.17M7.12M6.20M4.58M2.93M
Non-current liabilities:
Long term debt
642K1.05M092.72M45.65M
Deferred tax
00000
Other non-current liabilities
7K29K444K00
Total non-current liabilities
649K1.08M611K92.75M45.69M
Total liabilities
18.82M8.21M6.81M97.33M48.63M
Data sourceData sourceData source